The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.

Saved in:
Bibliographic Details
Title: The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
Authors: Vitale SR; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Clinical and Experimental Medicine, University of Catania, 95123, Catania, Italy.; Center of Experimental Oncology and Hematology, A.O.U. Policlinico 'G. Rodolico- San Marco', 95123, Catania, Italy., Ruigrok-Ritstier K; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Timmermans AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Foekens R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Trapman-Jansen AMAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Vigneri P; Department of Clinical and Experimental Medicine, University of Catania, 95123, Catania, Italy.; Center of Experimental Oncology and Hematology, A.O.U. Policlinico 'G. Rodolico- San Marco', 95123, Catania, Italy., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Cancer Genomics Netherlands, Rotterdam, The Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Cancer Genomics Netherlands, Rotterdam, The Netherlands., Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. m.p.h.m.jansen@erasmusmc.nl.
Source: BMC cancer [BMC Cancer] 2022 Feb 12; Vol. 22 (1), pp. 165. Date of Electronic Publication: 2022 Feb 12.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2407
DOI:10.1186/s12885-022-09265-1